Safety Issues and Rationale for Neoadjuvant Approaches in Renal Cell Carcinoma

被引：3
作者：
Bessede, Thomas [2 ]
Pignot, Geraldine [1 ]
Patard, Jean-Jacques [2 ]
机构：
[1] Univ Paris 05, Cochin Hosp, Dept Urol, F-75014 Paris, France
[2] Univ Paris 11, Bicetre Hosp, Dept Urol, Le Kremlin Bicetre, France
来源：
EUROPEAN UROLOGY | 2011年 / 60卷 / 05期
关键词：
CYTOREDUCTIVE NEPHRECTOMY; SUNITINIB; THERAPIES; ERA;
D O I：
10.1016/j.eururo.2011.06.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：972 / 974
页数：3
相关论文
共 50 条
[41]   Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localised Clear-Cell Renal Cell Carcinoma [J].
Voylenko, O. A. ;
Stakhovsky, O. E. ;
Vitruk, I. V. ;
Kononenko, O. A. ;
Pikul, M. V. ;
Semko, S. L. ;
Stakhovsky, E. O. .
ADVANCES IN UROLOGY, 2021, 2021
[42]   Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma [J].
Cowey, C. Lance ;
Amin, Chirag ;
Pruthi, Raj S. ;
Wallen, Eric M. ;
Nielsen, Matthew E. ;
Grigson, Gayle ;
Watkins, Cathy ;
Nance, Keith V. ;
Crane, Jeffrey ;
Jalkut, Mark ;
Moore, Dominic T. ;
Kim, William Y. ;
Godley, Paul A. ;
Whang, Young E. ;
Fielding, Julia R. ;
Rathmell, W. Kimryn .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) :1502-1507
[43]   Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial [J].
Bilen, Mehmet A. ;
Vo, BaoHan T. ;
Liu, Yuan ;
Greenwald, Rachel ;
Davarpanah, Amir H. ;
Mcguire, Donald ;
Shiradkar, Rakesh ;
Li, Liping ;
Midya, Adhishek ;
Nazha, Bassel ;
Brown, Jacqueline T. ;
Williams, Sierra ;
Session, Wilena ;
Russler, Greta ;
Caulfield, Sarah ;
Joshi, Shreyas S. ;
Narayan, Vikram M. ;
Filson, Christopher P. ;
Ogan, Kenneth ;
Kucuk, Omer ;
Carthon, Bradley Curtis ;
Del Balzo, Luke ;
Cohen, Athena ;
Boyanton, Adriana ;
Prokhnevska, Nataliya ;
Cardenas, Maria Andrea ;
Sobierajska, Ewelina ;
Jansen, Caroline S. ;
Patil, Dattatraya H. ;
Nicaise, Edouard ;
Osunkoya, Adeboye O. ;
Kissick, Haydn T. ;
Master, Viraj A. .
NATURE CANCER, 2025, 6 (03) :432-444
[44]   Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: Rationale and ongoing trials [J].
Hutson, Thomas E. ;
Sonpavde, Guru ;
Galsky, Matthew D. .
CLINICAL GENITOURINARY CANCER, 2006, 5 :S31-S39
[45]   Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma [J].
Chapin, Brian F. ;
Delacroix, Scott E., Jr. ;
Culp, Stephen H. ;
Gonzalez, Graciela M. Nogueras ;
Tannir, Nizar M. ;
Jonasch, Eric ;
Tamboli, Pheroz ;
Wood, Christopher G. .
EUROPEAN UROLOGY, 2011, 60 (05) :964-971
[46]   Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma [J].
Porta, Camillo ;
Gore, Martin E. ;
Rini, Brian I. ;
Escudier, Bernard ;
Hariharan, Subramanian ;
Charles, Lorna P. ;
Yang, Liqiang ;
DeAnnuntis, Liza ;
Motzer, Robert J. .
EUROPEAN UROLOGY, 2016, 69 (02) :345-351
[47]   Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma [J].
T E Hutson ;
R M Bukowski ;
B I Rini ;
M E Gore ;
J M Larkin ;
R A Figlin ;
C H Barrios ;
B Escudier ;
X Lin ;
K Fly ;
B Martell ;
E Matczak ;
R J Motzer .
British Journal of Cancer, 2014, 110 :1125-1132
[48]   Efficacy and safety of sunitinib in elderly patients with advanced renal cell carcinoma [J].
Fujita, Tetsuo ;
Hirayama, Takahiro ;
Ishii, Daisuke ;
Matsumoto, Kazumasa ;
Yoshida, Kazunari ;
Iwamura, Masatsugu .
MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (04) :394-398
[49]   Safety and Efficacy of Targeted Therapy for Renal Cell Carcinoma With Brain Metastasis [J].
Bastos, Diogo A. ;
Molina, Ana M. ;
Hatzoglou, Vaios ;
Jia, Xiaoyu ;
Velasco, Susanne ;
Patil, Sujata ;
Voss, Martin H. ;
Feldman, Darren R. ;
Motzer, Robert J. .
CLINICAL GENITOURINARY CANCER, 2015, 13 (01) :59-66
[50]   Safety and efficacy of sunitinib for advanced non-clear cell renal cell carcinoma [J].
Shi, Hong-Zhe ;
Tian, Jun ;
Li, Chang-Ling .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (04) :328-333
12345